CHAPTER 1. Industry Overview of Immunoassay Market
1.1. Definition and Scope
1.1.1. Definition of Immunoassay
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Immunoassay Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Immunoassay Market By Technology
1.2.3. Immunoassay Market By Product
1.2.4. Immunoassay Market By Specimen
1.2.5. Immunoassay Market By Application
1.2.6. Immunoassay Market By End-Use
1.2.7. Immunoassay Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Immunoassay Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Immunoassay Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2023
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023
4.2. R&D Status of Major Manufacturers in 2023
CHAPTER 5. Immunoassay Market By Technology
5.1. Introduction
5.2. Immunoassay Revenue By Technology
5.2.1. Immunoassay Revenue (USD Billion) and Forecast, By Technology, 2020-2032
5.2.2. Enzyme Immunoassay (EIA)s
5.2.2.1. Enzyme Immunoassay (EIA) Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.2. Fluorescence Immunoassays (FIA)
5.2.2.2.1. Fluorescence Immunoassays (FIA) Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.3. Chemiluminescence Immunoassays (CLIA)
5.2.2.3.1. Chemiluminescence Immunoassays (CLIA) Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Radioimmunoassay (RIA)
5.2.3.1. Radioimmunoassay (RIA) Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Rapid test
5.2.4.1. Rapid test Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.5. Others
5.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Immunoassay Market By Product
6.1. Introduction
6.2. Immunoassay Revenue By Product
6.2.1. Immunoassay Revenue (USD Billion) and Forecast, By Product, 2020-2032
6.2.2. Analyzers/instruments
6.2.2.1. Analyzers/instruments Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.2.2. Closed-ended systems
6.2.2.2.1. Closed-ended systems Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.2.3. Open-ended systems
6.2.2.3.1. Open-ended systems Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Reagents & kits
6.2.3.1. Reagents & kits Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3.2. ELISA Reagents & Kits
6.2.3.2.1. ELISA Reagents & Kits Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3.3. Rapid Test Reagents & Kits
6.2.3.3.1. Rapid Test Reagents & Kits Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3.4. ELISPOT Reagents & Kits
6.2.3.4.1. ELISPOT Reagents & Kits Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3.5. Western Blot Reagents & Kits
6.2.3.5.1. Western Blot Reagents & Kits Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3.6. Other Reagents & Kits
6.2.3.6.1. Other Reagents & Kits Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Software & services
6.2.4.1. Software & services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Immunoassay Market By Specimen
7.1. Introduction
7.2. Immunoassay Revenue By Specimen
7.2.1. Immunoassay Revenue (USD Billion) and Forecast, By Specimen, 2020-2032
7.2.2. Blood
7.2.2.1. Blood Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Saliva
7.2.3.1. Saliva Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4. Urine
7.2.4.1. Urine Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.5. Others Specimens
7.2.5.1. Others Specimens Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. Immunoassay Market By Application
8.1. Introduction
8.2. Immunoassay Revenue By Application
8.2.1. Immunoassay Revenue (USD Billion) and Forecast, By Application, 2020-2032
8.2.2. Endocrinology
8.2.2.1. Endocrinology Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.3. Therapeutic Drug Monitoring
8.2.3.1. Therapeutic Drug Monitoring Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.4. Autoimmune diseases
8.2.4.1. Autoimmune diseases Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.5. Infectious disease testing
8.2.5.1. Infectious Disease Testing Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.6. Cardiology
8.2.6.1. Cardiology Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.7. Oncology
8.2.7.1. Oncology Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.8. Others
8.2.8.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 9. Immunoassay Market By End-Use
9.1. Introduction
9.2. Immunoassay Revenue By End-Use
9.2.1. Immunoassay Revenue (USD Billion) and Forecast, By End-Use, 2020-2032
9.2.2. Hospitals
9.2.2.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
9.2.3. Pharmaceutical and biotech companies
9.2.3.1. Pharmaceutical and Biotech Companies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
9.2.4. Clinical laboratories
9.2.4.1. Clinical Laboratories Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
9.2.5. Academic research centers
9.2.5.1. Academic Research Centers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
9.2.6. Blood banks
9.2.6.1. Blood banks Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
9.2.7. Others
9.2.7.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 10. North America Immunoassay Market By Country
10.1. North America Immunoassay Market Overview
10.2. U.S.
10.2.1. U.S. Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032
10.2.2. U.S. Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032
10.2.3. U.S. Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032
10.2.4. U.S. Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032
10.2.5. U.S. Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032
10.3. Canada
10.3.1. Canada Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032
10.3.2. Canada Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032
10.3.3. Canada Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032
10.3.4. Canada Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032
10.3.5. Canada Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032
10.4. North America PEST Analysis
CHAPTER 11. Europe Immunoassay Market By Country
11.1. Europe Immunoassay Market Overview
11.2. U.K.
11.2.1. U.K. Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032
11.2.2. U.K. Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032
11.2.3. U.K. Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032
11.2.4. U.K. Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032
11.2.5. U.K. Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032
11.3. Germany
11.3.1. Germany Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032
11.3.2. Germany Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032
11.3.3. Germany Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032
11.3.4. Germany Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032
11.3.5. Germany Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032
11.4. France
11.4.1. France Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032
11.4.2. France Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032
11.4.3. France Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032
11.4.4. France Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032
11.4.5. France Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032
11.5. Spain
11.5.1. Spain Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032
11.5.2. Spain Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032
11.5.3. Spain Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032
11.5.4. Spain Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032
11.5.5. Spain Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032
11.6. Rest of Europe
11.6.1. Rest of Europe Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032
11.6.2. Rest of Europe Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032
11.6.3. Rest of Europe Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032
11.6.4. Rest of Europe Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032
11.6.5. Rest of Europe Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032
11.7. Europe PEST Analysis
CHAPTER 12. Asia Pacific Immunoassay Market By Country
12.1. Asia Pacific Immunoassay Market Overview
12.2. China
12.2.1. China Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032
12.2.2. China Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032
12.2.3. China Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032
12.2.4. China Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032
12.2.5. China Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032
12.3. Japan
12.3.1. Japan Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032
12.3.2. Japan Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032
12.3.3. Japan Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032
12.3.4. Japan Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032
12.3.5. Japan Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032
12.4. India
12.4.1. India Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032
12.4.2. India Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032
12.4.3. India Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032
12.4.4. India Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032
12.4.5. India Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032
12.5. Australia
12.5.1. Australia Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032
12.5.2. Australia Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032
12.5.3. Australia Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032
12.5.4. Australia Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032
12.5.5. Australia Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032
12.6. South Korea
12.6.1. South Korea Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032
12.6.2. South Korea Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032
12.6.3. South Korea Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032
12.6.4. South Korea Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032
12.6.5. South Korea Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032
12.7. Rest of Asia-Pacific
12.7.1. Rest of Asia-Pacific Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032
12.7.2. Rest of Asia-Pacific Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032
12.7.3. Rest of Asia-Pacific Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032
12.7.4. Rest of Asia-Pacific Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032
12.7.5. Rest of Asia-Pacific Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032
12.8. Asia Pacific PEST Analysis
CHAPTER 13. Latin America Immunoassay Market By Country
13.1. Latin America Immunoassay Market Overview
13.2. Brazil
13.2.1. Brazil Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032
13.2.2. Brazil Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032
13.2.3. Brazil Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032
13.2.4. Brazil Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032
13.2.5. Brazil Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032
13.3. Mexico
13.3.1. Mexico Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032
13.3.2. Mexico Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032
13.3.3. Mexico Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032
13.3.4. Mexico Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032
13.3.5. Mexico Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032
13.4. Rest of Latin America
13.4.1. Rest of Latin America Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032
13.4.2. Rest of Latin America Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032
13.4.3. Rest of Latin America Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032
13.4.4. Rest of Latin America Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032
13.4.5. Rest of Latin America Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032
13.5. Latin America PEST Analysis
CHAPTER 14. Middle East & Africa Immunoassay Market By Country
14.1. Middle East & Africa Immunoassay Market Overview
14.2. GCC
14.2.1. GCC Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032
14.2.2. GCC Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032
14.2.3. GCC Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032
14.2.4. GCC Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032
14.2.5. GCC Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032
14.3. South Africa
14.3.1. South Africa Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032
14.3.2. South Africa Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032
14.3.3. South Africa Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032
14.3.4. South Africa Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032
14.3.5. South Africa Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032
14.4. Rest of Middle East & Africa
14.4.1. Rest of Middle East & Africa Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032
14.4.2. Rest of Middle East & Africa Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032
14.4.3. Rest of Middle East & Africa Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032
14.4.4. Rest of Middle East & Africa Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032
14.4.5. Rest of Middle East & Africa Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032
14.5. Middle East & Africa PEST Analysis
CHAPTER 15. Player Analysis Of Immunoassay Market
15.1. Immunoassay Market Company Share Analysis
15.2. Competition Matrix
15.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
15.2.2. New Product Launches and Product Enhancements
15.2.3. Mergers And Acquisition In Global Immunoassay Market
15.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 16. Company Profile
16.1. Thermo Fisher Scientific, Inc
16.1.1. Company Snapshot
16.1.2. Business Overview
16.1.3. Financial Overview
16.1.3.1. Revenue (USD Billion), 2023
16.1.3.2. Thermo Fisher Scientific, Inc, 2023 Immunoassay Business Regional Distribution
16.1.4. Product /Service and Specification
16.1.5. Recent Developments & Business Strategy
16.2. Abbott Laboratories
16.3. bioMérieux SA
16.4. Becton, Dickinson and Company
16.5. Abbott Laboratories
16.6. F. Hoffmann-La Roche AG
16.7. Danaher Corporation (Beckman Coulter)
16.8. Siemens Healthineers
16.9. Quidel Corporation
16.10. Sysmex Corporation
16.11. Bio-Rad Laboratories, Inc
The immunoassay market size was valued at USD 31.4 Billion in 2023.
The CAGR of Immunoassay is 5.1% during the analysis period of 2024 to 2032.
The key players operating in the global market are including Thermo Fisher Scientific, Inc, Abbott Laboratories, bioMérieux SA, Becton, Dickinson and Company, Thermo Fisher Scientific, Inc, F. Hoffmann-La Roche AG, Danaher Corporation (Beckman Coulter), Siemens Healthineers, Quidel Corporation; Sysmex Corporation, and Bio-Rad Laboratories, Inc.
North America held the dominating position in immunoassay industry during the analysis period of 2024 to 2032.
Asia-Pacific region exhibited fastest growing CAGR for market of immunoassay during the analysis period of 2024 to 2032.
The current trends and dynamics in the immunoassay industry include rising prevalence of chronic and infectious diseases fuels the demand for immunoassay diagnostics, technological advancements in immunoassay platforms improve accuracy and speed, and growing demand for point-of-care testing (POCT) boosts market adoption.
The enzyme immunoassay (EIA) held the maximum share of the Immunoassay industry.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date